249 related articles for article (PubMed ID: 11148685)
1. Familial thyroid cancer.
Alsanea O; Clark OH
Curr Opin Oncol; 2001 Jan; 13(1):44-51. PubMed ID: 11148685
[TBL] [Abstract][Full Text] [Related]
2. Current management of medullary thyroid cancer.
Sippel RS; Kunnimalaiyaan M; Chen H
Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
[TBL] [Abstract][Full Text] [Related]
3. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members.
Shaha AR; Cohen T; Ghossein R; Tuttle RM
Laryngoscope; 2006 Sep; 116(9):1704-7. PubMed ID: 16955009
[TBL] [Abstract][Full Text] [Related]
4. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
[TBL] [Abstract][Full Text] [Related]
6. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
7. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
[TBL] [Abstract][Full Text] [Related]
8. Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986.
Girelli ME; Nacamulli D; Pelizzo MR; De Vido D; Mian C; Piccolo M; Busnardo B
Thyroid; 1998 Jun; 8(6):517-23. PubMed ID: 9669290
[TBL] [Abstract][Full Text] [Related]
9. Medullary carcinoma of the thyroid gland.
Wells SA; Franz C
World J Surg; 2000 Aug; 24(8):952-6. PubMed ID: 10865039
[TBL] [Abstract][Full Text] [Related]
10. Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.
El Lakis M; Giannakou A; Nockel PJ; Wiseman D; Gara SK; Patel D; Sater ZA; Kushchayeva YY; Klubo-Gwiezdzinska J; Nilubol N; Merino MJ; Kebebew E
Surgery; 2019 Jan; 165(1):50-57. PubMed ID: 30327187
[TBL] [Abstract][Full Text] [Related]
11. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
[TBL] [Abstract][Full Text] [Related]
12. Familial nonmedullary thyroid cancer.
Alsanea O
Curr Treat Options Oncol; 2000 Oct; 1(4):345-51. PubMed ID: 12061376
[TBL] [Abstract][Full Text] [Related]
13. [Preventive radical surgery of C-cell carcinoma in MEN-II syndrome based on genetic screening].
Röher HD; Simon D; Goretzki PE; Höppner W; Lederbogen S; Seppel T
Chirurg; 1995 Dec; 66(12):1196-202. PubMed ID: 8582162
[TBL] [Abstract][Full Text] [Related]
14. [Medullary cancer of the thyroid].
Modigliani E
Rev Med Interne; 1999 Jun; 20(6):490-503. PubMed ID: 10422141
[TBL] [Abstract][Full Text] [Related]
15. Familial thyroid carcinoma: a diagnostic algorithm.
Dotto J; Nosé V
Adv Anat Pathol; 2008 Nov; 15(6):332-49. PubMed ID: 18948764
[TBL] [Abstract][Full Text] [Related]
16. The surgical management of medullary thyroid cancer.
Dackiw AP
Otolaryngol Clin North Am; 2010 Apr; 43(2):365-74, ix. PubMed ID: 20510719
[TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasia: paediatric perspective.
Rodriguez-Sánchez A; López-Menchero C; Rodríguez-Arnao MD
J Pediatr Endocrinol Metab; 2005 Dec; 18 Suppl 1():1237-44. PubMed ID: 16398454
[TBL] [Abstract][Full Text] [Related]
18. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
[TBL] [Abstract][Full Text] [Related]
19. [Multiple endocrine neoplasia syndromes. Type 2].
Juodele L; Juozaityte E; Zindzius A; Pundzius J
Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
[TBL] [Abstract][Full Text] [Related]
20. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation.
Feldman GL; Edmonds MW; Ainsworth PJ; Schuffenecker I; Lenoir GM; Saxe AW; Talpos GB; Roberson J; Petrucelli N; Jackson CE
Surgery; 2000 Jul; 128(1):93-8. PubMed ID: 10876191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
